Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Share-based Compensation (2020 - 2024)

RAPT Therapeutics' Share-based Compensation history spans 5 years, with the latest figure at $4.6 million for Q4 2024.

  • For Q4 2024, Share-based Compensation rose 3.61% year-over-year to $4.6 million; the TTM value through Dec 2024 reached $19.9 million, up 16.64%, while the annual FY2024 figure was $19.9 million, 16.64% up from the prior year.
  • Share-based Compensation for Q4 2024 was $4.6 million at RAPT Therapeutics, up from $4.6 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $5.4 million in Q1 2024 and bottomed at $2.0 million in Q3 2020.
  • The 5-year median for Share-based Compensation is $2.9 million (2021), against an average of $3.3 million.
  • The largest annual shift saw Share-based Compensation fell 18.45% in 2021 before it surged 58.65% in 2023.
  • A 5-year view of Share-based Compensation shows it stood at $2.6 million in 2020, then decreased by 18.45% to $2.1 million in 2021, then skyrocketed by 45.01% to $3.0 million in 2022, then soared by 46.41% to $4.4 million in 2023, then rose by 3.61% to $4.6 million in 2024.
  • Per Business Quant, the three most recent readings for RAPT's Share-based Compensation are $4.6 million (Q4 2024), $4.6 million (Q3 2024), and $5.4 million (Q2 2024).